MDxHealth SA ADR (MDXH) has had the highest return this decade by a US stock in the Biotechnology Industry, returning 381,718.2%.

ASSET	DECADE	% RETURN
MDxHealth SA ADR (MDXH)	2020s	381,718.18%
Azitra (AZTR)	2020s	12,292.86%
180 Life Sciences (ATNF)	2020s	6,946.26%
Regencell Bioscience (RGC)	2020s	5,596.64%
NewAmsterdam Pharma Company NV Warrant (NAMSW)	2020s	2,641%
Summit Therapeutics (SMMT)	2020s	1,333.13%
Celldex Therapeutics (CLDX)	2020s	1,111.16%
Protagonist Therapeutics (PTGX)	2020s	1,016.64%
COSCIENS Biopharma (CSCI)	2020s	892%
Indivior PLC Ordinary Shares (INDV)	2020s	746.45%
Abivax SA American Depositary Shares (ABVX)	2020s	724.4%
Insmed (INSM)	2020s	586.52%
Merus (MRUS)	2020s	572.7%
Belite Bio Inc ADR (BLTE)	2020s	538.16%
Cytokinetics (CYTK)	2020s	460.06%
Cogent Biosciences (COGT)	2020s	447.3%
Catalyst Pharmaceuticals (CPRX)	2020s	436.84%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	2020s	423.95%
Capricor Therapeutics (CAPR)	2020s	416.92%
Natera (NTRA)	2020s	414.38%
argenx NV ADR (ARGX)	2020s	398.79%
United Therapeutics (UTHR)	2020s	398.09%
Nuvalent (NUVL)	2020s	395.86%
Madrigal Pharmaceuticals (MDGL)	2020s	366.75%
Arcellx (ACLX)	2020s	353.84%